Altre lingue AccuStem Sciences, Inc.

Azioni

ACUT

US00444A1016

Mercato chiuso - OTC Markets Altri mercati azionari 20:38:28 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,388 ^USD	+40,58%		0,00%	-37,99%

22/03	AccuStem Sciences, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	AccuStem Sciences, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	17/07/23
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	17/07/23
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	11/07/23
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	09/06/23
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	09/06/23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23
AccuStem Announce Strategic Clinical and Operational Partnership	31/05/23
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	31/05/23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/05/23
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	02/05/23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/02/23
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	06/12/22
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22/11/22
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	16/11/22
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors	16/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue AccuStem Sciences, Inc.

Azioni

ACUT

US00444A1016

Altre lingue

Filtri